Alnylam Pharmaceuticals’ Amvuttra (vutrisiran) has been approved by the European Commission (EC) to treat adults with ...

By combining different treatment options – especially those involving immuno-oncology (IO) – researchers aim to develop ...

Results from the study’s open-label period, presented at this year’s European Renal Association Congress, showed that ...

Merck & Co – known as MSD outside the US and Canada – has announced that its respiratory syncytial virus (RSV) preventive ...

The PM (Pharmaceutical Marketing) Society is delighted to announce a new partnership with the CIM (Chartered Institute of ...

As the concept of sustainability gains traction in healthcare, it is beginning to influence how value is assessed and ...

The American Diabetes Association’s 85th Scientific Sessions is almost here, and Medscape is ready to make an impact in the ...

The authorisation comes three months after the MHRA approved Johnson & Johnson’s Lazcluze (lazertinib), which is also ...

What does SAY’s healthcare communications crystal ball reveal for the coming year? We’ve looked at what we can expect to see ...

Mental health awareness has seen incredible change – in no small part down to communications teams in private and public ...

Otsuka Pharmaceutical has shared positive results from a late-stage study of its investigational monoclonal antibody ...

Artificial intelligence (AI) is rapidly transforming industries. Healthcare is no exception. The conversation around AI’s ...